John Maraganore

Non Executive / Other Non-Executive
  • Director Verified:
  • No
Login/ Register  to follow report
Company:

About

Dr. John Maraganore serves as the CEO and a Director of Alnylam, the company that translated Nobel-prize winning RNA interference (RNAi) into a whole new class of innovative medicines. Dr. Maraganore supports the industry at large, serving on the boards of directors for growing biotech companies like Agios Pharmaceuticals. He is a former chair of the Biotechnology Industry Organization (BIO) Board and member of the BIO Executive Committee. Before joining Alnylam, Dr. Maraganore served as Senior Vice President, Strategic Product Development for Millennium Pharmaceuticals, Inc. Prior to Millennium, Dr. Maraganore served as Director of Molecular Biology and Director of Market and Business Development at Biogen, Inc., where he invented and led the discovery and development of Angiomax™ (bivalirudin for injection, formerly Hirulog™) currently marketed by The Medicines Company. Dr. Maraganore received his M.S. and Ph.D. in biochemistry and molecular biology at the University of Chicago.

 

Personal Details

Title: Dr
Surname: Maraganore
DoB: 01/01/1962
Age: 64 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: B.A, M.S, Ph.D Biochemistry and Molecular Biology
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

CompanyCommitteePositionDate Appointed
BoardOther Executive01/02/2022

 

Working history

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
Takeda PharmaceuticalBoardMember01/06/2022

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF